Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $901M | $908M | $882M | $929M | $892M | $1.06B | $878M | $950M | $1.05B | $1.19B |
| Revenue growth | — | 0.8% | -2.9% | 5.3% | -3.9% | 19.1% | -17.4% | 8.1% | 10.7% | 13.2% |
| Operating income | $560M | $315M | $498M | $552M | — | — | — | — | — | — |
| Operating margin | 62.2% | 34.7% | 56.4% | 59.4% | — | — | — | — | — | — |
| Net income | $383M | $105M | $294M | $352M | $164M | $428M | $439M | $242M | $406M | $590M |
| Net margin | 42.6% | 11.5% | 33.3% | 37.9% | 18.3% | 40.3% | 50.0% | 25.5% | 38.6% | 49.6% |
| EPS (diluted) | $1.90 | $0.51 | $1.40 | $1.58 | $0.70 | $1.75 | $1.80 | $1.00 | $1.55 | $1.94 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $625M | $578M | $499M | $554M | $708M | $722M | $626M | $618M | $749M | $879M |
| Share buybacks | — | — | — | — | — | — | $142M | — | — | — |
| Dividends paid | $453M | $503M | $529M | $564M | $612M | $638M | $633M | $644M | $685M | $780M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $93.7M | $85.9M | $10.3M | $24.1M | $164M | $20.5M | $297M | $443M | $518M | $27.0M |
| Total assets | $8.95B | $8.77B | $8.59B | $9.80B | $9.50B | $9.64B | $9.41B | $9.12B | $9.90B | $10.0B |
| Total liabilities | $4.74B | $4.89B | $4.83B | $5.46B | $5.46B | $5.53B | $5.60B | $5.36B | $5.17B | $4.61B |
| Long-term debt | $4.37B | $4.57B | $4.54B | $5.14B | $5.17B | $5.25B | $5.29B | $5.07B | $4.84B | $4.26B |
| Shareholders' equity | $3.86B | $3.56B | $3.44B | $4.14B | $3.84B | $3.91B | $3.61B | $3.57B | $4.54B | $5.18B |
| Retained earnings | $1.74B | $1.84B | $2.13B | $2.46B | $2.59B | $3.01B | $3.44B | $3.68B | $4.09B | $4.68B |
| Shares (wtd avg diluted) | 202M | 207M | 210M | 222M | 235M | 244M | 244M | 250M | 270M | 305M |
Every figure is extracted from OMEGA HEALTHCARE INVESTORS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.